3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pegaspargase
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Asparaginase
2
tislelizumab
1
sugemalimab
1
selinexor
1
pembrolizumab
1
fludarabine
1
Vorinostat
1
Transplantation
1
Tomography, X-Ray Computed
1
Sirolimus
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
IMC-001
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
duvelisib
×
90 days
×
Clear all
No trials found.